Panagora Asset Management Inc. Trims Stock Position in Oscar Health, Inc. (NYSE:OSCR)

Panagora Asset Management Inc. cut its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 19.7% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 221,920 shares of the company’s stock after selling 54,444 shares during the quarter. Panagora Asset Management Inc.’s holdings in Oscar Health were worth $2,031,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in OSCR. SG Americas Securities LLC purchased a new position in Oscar Health during the third quarter worth about $62,000. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Oscar Health by 19.5% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,569 shares of the company’s stock worth $137,000 after purchasing an additional 4,011 shares during the period. TD Asset Management Inc purchased a new position in shares of Oscar Health in the 3rd quarter worth about $634,000. Principal Financial Group Inc. raised its holdings in shares of Oscar Health by 35.9% in the 3rd quarter. Principal Financial Group Inc. now owns 22,522 shares of the company’s stock worth $125,000 after purchasing an additional 5,954 shares during the period. Finally, Capula Management Ltd purchased a new position in shares of Oscar Health in the 3rd quarter worth about $781,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Trading Down 2.3 %

OSCR stock opened at $22.00 on Tuesday. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.29. Oscar Health, Inc. has a 1 year low of $4.72 and a 1 year high of $23.34. The stock has a 50-day simple moving average of $16.65 and a 200-day simple moving average of $13.04.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Tuesday, May 7th. The company reported $0.62 earnings per share for the quarter, beating analysts’ consensus estimates of $0.28 by $0.34. Oscar Health had a negative return on equity of 5.77% and a negative net margin of 0.82%. The firm had revenue of $2.14 billion during the quarter, compared to analyst estimates of $1.99 billion. During the same quarter last year, the firm earned ($0.18) EPS. Oscar Health’s quarterly revenue was up 45.8% on a year-over-year basis. Sell-side analysts forecast that Oscar Health, Inc. will post -0.04 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently commented on OSCR shares. Wells Fargo & Company raised their price objective on Oscar Health from $20.00 to $24.00 and gave the stock an “overweight” rating in a report on Thursday, May 9th. Raymond James started coverage on Oscar Health in a report on Friday, March 22nd. They issued an “outperform” rating and a $20.00 price objective on the stock. The Goldman Sachs Group raised their price objective on Oscar Health from $16.00 to $21.00 and gave the stock a “neutral” rating in a report on Thursday, May 9th. TheStreet upgraded Oscar Health from a “d” rating to a “c-” rating in a report on Wednesday, February 21st. Finally, Bank of America increased their target price on Oscar Health from $22.00 to $25.00 and gave the company a “buy” rating in a research note on Monday. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, Oscar Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $17.67.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.